GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. - Wikidata - wikimedia - TriplyDB

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

http://www.wikidata.org/entity/Q37213617

about

Endocrine manifestations and management of Prader-Willi syndrome Growth hormone therapy for Prader-willi syndrome: challenges and solutions GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes Syndromic disorders with short stature Bridging the gap: metabolic and endocrine care of patients during transition The neurobiology of the Prader-Willi phenotype of fragile X syndrome Growth hormone treatment in non-growth hormone-deficient children Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome Genetic Counseling for Diabetes Mellitus.Prader-Willi syndrome: a single center's experience in Korea Prader-Willi syndrome and growth hormone deficiency Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome.Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome An examination of the effects of different doses of recombinant human growth hormone on children with growth hormone deficiency.Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study Central Hypoventilation Syndromes.What is the value of growth hormone therapy in Prader Willi syndrome?Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.Clinical and Molecular Characterization of Prader-Willi Syndrome.Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome.Recent Advances in Imprinting Disorders.Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.Growth Charts for Prader-Willi Syndrome During Growth Hormone Treatment.Evaluation of the hypothalamic-pituitary-adrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome.Disorders of Sleep and Ventilatory Control in Prader-Willi Syndrome Gastric Dilatation and Abdominal Compartment Syndrome in a Child with Prader-Willi Syndrome Growth Hormone Therapy in Adults with Prader-Willi Syndrome.Pituitary-Adrenal Axis in Prader Willi Syndrome.Medication Trials for Hyperphagia and Food-Related Behaviors in Prader-Willi Syndrome.Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.Review of Prader-Willi syndrome: the endocrine approach.Short Stature Diagnosis and Referral.Positive effect of growth hormone treatment in maternal uniparental disomy chromosome 14.A Pediatric Patient with Idiopathic Short Stature Who Developed Obstructive Sleep Apnea after Starting Growth Hormone Replacement Therapy.[Prader-Willi syndrome in 2015].A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy.Impact of transitional care on endocrine and anthropometric parameters in Prader-Willi syndrome.

P2860

Q21245401-F9469152-3276-4E8E-BB30-5136F516266F Q26744053-6E9F72D6-8690-41DB-8DD2-3BF240987C1C Q26777290-9D3FD340-7F5E-4ABB-B02F-90C3B508C426 Q26827423-6BE7CA95-17C1-4DF7-8ADA-7DA257D44347 Q26849438-73BAFB85-6BE3-44C2-958F-5649FDCF9656 Q28069698-0DB3E4AB-C5AE-4604-8D4F-8902B4659C15 Q28078294-2E54F0F7-619F-484D-B11D-91A62D70F1BF Q33726962-C7DE1361-7946-4F83-866B-E31A3C9AC33E Q33851054-B2C0642B-9C3D-474E-8EB8-558A986D3829 Q33899140-6A1D5465-97AC-48BF-9587-2B1308C5A72A Q34022930-87A80F44-7AF1-4BFF-9BDE-214D103AEAD9 Q34077985-CA5C41E5-0385-4918-A207-1959A2D1A65A Q35908156-0F6C477C-EAE3-488D-BE42-00416E1364B0 Q36029803-4ADAAC59-406E-4656-B626-3957155F1392 Q36240989-DA1A0456-5F1D-471D-8340-E99B2533F94D Q36327121-77061FAD-F7B1-4155-9F54-4EEC12C69E6B Q36824977-C8875CE1-7CA5-43F0-BB76-E06662E2F48A Q37093078-7C4E07F8-03BD-4FB8-AFF8-4597A4022B5C Q37657667-28665D6C-C72F-45F3-8769-62CAC99107C0 Q38155729-D916BE0C-AD3A-489B-858F-2B6B009DDB3F Q38286211-6F3CF10C-436D-44B6-B56E-9558F37125C5 Q38703279-619086CC-B375-4E4E-91BE-72C72C6157A8 Q38835532-677E39F2-7BE8-4E6D-8097-FD4624F90FD2 Q38882121-DACF4BCF-EC72-4BDD-A5CA-1C83D4A237C1 Q38900041-7F2DB427-F1F1-41C8-A2DB-96E99360D7F3 Q40026342-41C4DC87-FD25-4C15-AE78-C453A666ADD0 Q40585624-DDCB2BD3-9DA5-4BA8-8150-7F18ED352763 Q41778628-ECD1ABB7-4B63-43E0-9CE2-71B5712E545A Q41892369-F7F94DD6-5874-4108-9559-CC6F00392BF5 Q41951669-D22470A2-60A9-4330-8454-954D545D9809 Q42168563-86C538FE-4255-48A5-9B44-8F86A0D306EA Q42343442-2DE5C98E-9AF9-4FA5-86FE-4BCACAC075AC Q45205513-62488DAA-F51B-4896-B63E-314E8ECBB9A0 Q47104160-B5365594-CE36-492C-BC0C-DD201EBC7C38 Q47555739-4E39F41D-D3B2-4FE9-833F-4C1EBC55BF05 Q49018397-7C3F4270-7C0F-46E6-A4EF-872C0F43C259 Q49175690-9E018E9E-B2C8-4136-914D-B4A616108F73 Q50554617-D2F464BB-294D-4BA5-97FB-91580627AE0C Q51257669-B27A9ED6-0D10-4DAB-A106-261A5C275A8E Q52318747-43E1806A-3F6A-4EF1-AE1C-09FAE6FB20BF

P2860

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

http://www.wikidata.org/entity/Q37213617

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

GrowthHormone Research Society ...... rapy in Prader-Willi syndrome.

@en

GrowthHormone Research Society ...... rapy in Prader-Willi syndrome.

@nl

type

label

GrowthHormone Research Society ...... rapy in Prader-Willi syndrome.

@en

GrowthHormone Research Society ...... rapy in Prader-Willi syndrome.

@nl

prefLabel

GrowthHormone Research Society ...... rapy in Prader-Willi syndrome.

@en

GrowthHormone Research Society ...... rapy in Prader-Willi syndrome.

@nl

P1433

Q37213617-065731CD-65A7-4023-9C9D-6C2B6762E301

P1476

Q37213617-3B99C962-48D5-4125-9AF2-1B6C4164F94F

P2093

Q37213617-124655BE-3EA7-4C63-A51B-5E38B5A7D114

Q37213617-3D770603-D114-4C6A-A3AB-B7EF8428A7B1

Q37213617-76848F32-7429-418E-89E3-BE986C8055E1

Q37213617-BE7F46E9-A885-4712-ADE7-984793993AF3

Q37213617-BF454188-8501-4251-A9EF-515B056EFC89

Q37213617-E9EE373D-A4CC-43F1-85B1-DC0C644D8967

Q37213617-EBC67B57-E8A7-413B-AE94-3EA99B72C685

P275

Q37213617-9FFF11D4-9745-4482-914D-42EED8DD19FC

P2860

Q37213617-0202C704-22D5-4C3E-9A27-B989CABC22FB

Q37213617-07EE50BB-BE87-4F5B-AFB9-020075CAFD92

Q37213617-09A37568-9E8B-4193-9B5A-6778675A47A8

Q37213617-13CD9B9D-FB85-460C-BC1D-DA798E151561

Q37213617-150E63B1-9224-4A82-888E-F8BD94DE6E7E

Q37213617-15D619D4-FA2E-4227-8D92-C1E7D8DD237A

Q37213617-169CE159-684E-43FA-9870-817D63BA4223

Q37213617-1742C008-EE3B-4F04-A4D8-441A62BB773C

Q37213617-1AA7AEF5-A343-4F94-A4B4-0312DEE8EB37

Q37213617-1BD32ADE-7994-4766-A282-4D40676DF9D1

P304

Q37213617-98442B9D-B364-4833-9792-9BBEBCB27564

P31

Q37213617-AB84918B-F544-4604-BF04-5C13F626E0F2

Q37213617-FFCD2FE6-8E92-4871-A2F3-3582C4A78D24

P356

Q37213617-A1FE9281-091E-4B7D-86AC-C9D26075B531

P407

Q37213617-44BA1C0C-D556-43AD-A1C0-895BFCE27F2A

P433

Q37213617-3B1030A0-359C-44C2-BF76-A848FA7A3281

P478

Q37213617-0547B843-221B-4BE8-BA90-C209816F2BB4

P5008

Q37213617-5C727713-4390-47F1-80FB-48D50586E8C9

P577

Q37213617-3C813279-817F-489B-B971-34B6875131BC

Q37213617-CC2A5993-7A40-4DE6-A090-E856D16CB1A5

P698

Q37213617-CCB33BCF-A0E9-4E49-86D6-51AD7DFE9E19

P921

Q37213617-85040DB7-04F6-49B9-90AC-85A0CD90B6AC

Q37213617-B508C068-5FAF-48D0-B66A-C3CF66A36333

Q37213617-D12B9737-1389-43FA-A8E6-61955EEA2597

Q37213617-DB2DA9F3-D158-4E86-8B12-5F9DA9F7A147

P932

Q37213617-6BD2217F-C6F7-4257-A29D-F6D2F4F41E27

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

GrowthHormone Research Society ...... rapy in Prader-Willi syndrome.

@en

P2093

2011 Growth Hormone in Prader- ...... idelines Workshop Participants

http://www.w3.org/2001/XMLSchema#string

Charlotte Höybye

http://www.w3.org/2001/XMLSchema#string

Cheri L Deal

http://www.w3.org/2001/XMLSchema#string

David B Allen

http://www.w3.org/2001/XMLSchema#string

Jens Sandahl Christiansen

http://www.w3.org/2001/XMLSchema#string

Maïthé Tauber

http://www.w3.org/2001/XMLSchema#string

Michèle Tony

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome

Specific treatment of Prader-Willi syndrome through cyclical rehabilitation programmes.

Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).

Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.

Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database.

Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.

Abnormal ventilatory responses in patients with Prader-Willi syndrome.

Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients

Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.

Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.

P304

E1072-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2012-3888

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23543664

http://www.w3.org/2001/XMLSchema#string

P921

Prader–Willi syndrome

P932

3789886

http://www.w3.org/2001/XMLSchema#string